Prevalence of gout and hyperuricemia in the US general population: The National Health and Nutrition Examination Survey 2007-2008
Top Cited Papers
- 27 September 2011
- journal article
- gout
- Published by Wiley in Arthritis & Rheumatism
- Vol. 63 (10), 3136-3141
- https://doi.org/10.1002/art.30520
Abstract
To estimate the prevalence of gout and hyperuricemia based on the latest nationally representative sample of US men and women (National Health and Nutrition Examination Survey [NHANES] 2007-2008). Using data from 5,707 participants in NHANES 2007-2008, we estimated the prevalence of gout and hyperuricemia. During home interviews for NHANES 2007-2008, all participants were asked about a history of health professional- or physician-diagnosed gout. Our primary definition of hyperuricemia was a serum urate level of >7.0 mg/dl for men and >5.7 mg/dl for women. We explored potential secular trends in these estimates and their possible explanations by comparing them with estimates based on 18,825 participants in NHANES-III (1988-1994). The prevalence of gout among US adults in 2007-2008 was 3.9% (8.3 million individuals). The prevalence among men was 5.9% (6.1 million), and the prevalence among women was 2.0% (2.2 million). The mean serum urate levels were 6.14 mg/dl among men and 4.87 mg/dl among women, corresponding to hyperuricemia prevalences of 21.2% and 21.6%, respectively. These estimates were higher than those in NHANES-III, with differences of 1.2% in the prevalence of gout (95% confidence interval [95% CI] 0.6, 1.9), 0.15 mg/dl in the serum urate level (95% CI 0.07, 0.24), and 3.2% in the prevalence of hyperuricemia (95% CI 1.2, 5.2). These differences were substantially attenuated after adjusting for body mass index and/or hypertension. These findings from nationally representative samples of US adults suggest that the prevalence of both gout and hyperuricemia remains substantial and may have increased over the past 2 decades, which is likely related to increasing frequencies of adiposity and hypertension.Keywords
Funding Information
- Takeda Pharmaceuticals International
This publication has 36 references indexed in Scilit:
- Coffee consumption and risk of incident gout in women: the Nurses’ Health StudyThe American Journal of Clinical Nutrition, 2010
- Sugar-Sweetened Beverages, Serum Uric Acid, and Blood Pressure in AdolescentsThe Journal of Pediatrics, 2009
- Vitamin C Intake and the Risk of Gout in MenJAMA Internal Medicine, 2009
- Soft drinks, fructose consumption, and the risk of gout in men: prospective cohort studyBMJ, 2008
- Estimates of the prevalence of arthritis and other rheumatic conditions in the United States: Part IIArthritis & Rheumatism, 2007
- EULAR evidence based recommendations for gout. Part II: Management. Report of a task force of the EULAR Standing Committee For International Clinical Studies Including Therapeutics (ESCISIT)Annals Of The Rheumatic Diseases, 2006
- Febuxostat Compared with Allopurinol in Patients with Hyperuricemia and GoutThe New England Journal of Medicine, 2005
- Obesity, Weight Change, Hypertension, Diuretic Use, and Risk of Gout in MenArchives of Internal Medicine, 2005
- Preliminary criteria for the classification of the acute arthritis of primary goutArthritis & Rheumatism, 1977
- Gout in a New England town. A prevalence study in Sudbury, Massachusetts.Annals Of The Rheumatic Diseases, 1972